unicycive.com (UNCY) - מזומנים למניה אחת

סמל תאגידי ולוגו של unicycive.com (UNCY)

The development of Unicycive Therapeutics (UNCY) relies on a sovereign cycle of medical tests in nephrology, where liquid reserves offset market volatility. The business model is based on outsourcing production and research, which eliminates massive capital expenditures. The absence of commercial sales makes the company dependent on capital burn, meaning changes in cash per share are critically important. The value of 2.00 determines this parameter level.

UNCY Unicycive: מזומנים למניה בטווח 04.07.2022 - 20.11.2026

פילוחים אנליטיים של חברת Unicycive Therapeutics, Inc. (UNCY)

- שווי שוק ותחזית יעד של אנליסטים:
- פרטי פוזיציית מזומנים ותזרימי מזומנים:
ניתוח מסכם של החברה:UNCY (Unicycive Therapeutics)
מוצר המיוצר על ידי unicycive.com

For Unicycive Therapeutics (UNCY), the level of liquid assets per share reflects financial stability as the company prepares for the final stages of drug trials. This metric demonstrates the volume of available cash distributed across the total issuance of securities. It measures the business's real margin of safety, excluding speculative market expectations. Growth in this indicator guarantees the coverage of production and certification costs for the therapy. It is critical for investors to balance capital security with potential returns.